Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Subsequent Events (Details Textual)

v3.8.0.1
Note 12 - Subsequent Events (Details Textual) - Subsequent Event [Member] - USD ($)
$ in Millions
Feb. 01, 2018
Jan. 02, 2018
Atlanta Biologicals [Member]    
Business Combination, Consideration Transferred   $ 50.0
Eurocell Diagnostics, SAS [Member]    
Business Combination, Consideration Transferred $ 7.5